Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add filters








Language
Year range
1.
Gulf Medical University: Proceedings. 2015; (4-5 Oral): 139-146
in English | IMEMR | ID: emr-188397

ABSTRACT

Bacterial artificial chromosomes [BACs]-on-Beads [BoBs] is one of the novel and rapid technologies that has been a part of recent advances in genomic technologies. BACs-on- Beads technology [Trade Mark] that assists in speedy detection of copy number changes [CNVs] in targeted genomic regions from minimal amount of DNA. We compared this molecular multiplex, bead-based suspension array that is used in prenatal invasive testing, with conventional cytogenetic and G-banded karyotype techniques. We present the initial BoBs analysis data of 4 patients referred to CABRI with congenital malformations. As per the manufacture's information the targeted region covers at least 4-5 bacs for each region. The selected loci represent the relatively common chromosomal syndromes associated with deletions that can be missed by karyotype analysis. The syndromes are known with definable phenotype and deletion as the major means giving rise to the syndrome. In addition to this the BAC's for the common aneuploidies of chromosomes 13, 18, 21, X, and Y are also present. The method not only detected the known trisomy 21 but also identified a deletion on the long arm of chromosome 7 at q11.2 region that represents the Williams - Beuran Syndrome [WBS] critical region in a patient with suspected trisomy 21. BoBs is potentially a very useful first row test for aneuploidy detection because of its lower cost and rapid detection with minimal amount of DNA especially in newborns with suspected congenital malformations. The results suggest that it is a reliable technique to detect common microdeletions that get missed out by conventional chromosomal analysis

2.
Gulf Medical University: Proceedings. 2015; (4-5 Poster): 78-84
in English | IMEMR | ID: emr-188407

ABSTRACT

This study was done with a view to find a correlation between two molecular tests for beta Thalassemia, our in-house developed haemoglobin DNA mutation analysis using ARMS PCR and a Commercial Line Probe Assay. De-identified samples from known beta thalassemia patients characterised by HPLC for HbA2, Peripheral smear [Target cells] and CBC [microcytosis and erythrocytosis] were used for the study. DNA was extracted using the DTAB/CTAB method. Amplified DNA from the samples was hybridised for mutations using a line probe assay. The extracted DNA was also examined for wild type genes and mutant genes using an Amplification refractory mutation system [ARMS] PCR. In this study fifteen beta Thalassemia patients were involved. The in-house ARMS PCR tested for six mutations and detected thalassemia trait in 66.7% of the samples tested for. The line probe assay tested for 22 mutations and detected thalassemia trait in 93.7% of cases examined. One case was missed by both methods and will require sequencing. The importance of stratification of testing for a cost effective strategy for Thalassemia diagnostics is discussed

3.
Gulf Medical University: Proceedings. 2015; (4-5 Poster): 85-89
in English | IMEMR | ID: emr-188408

ABSTRACT

HLA-B 27 is a human leukocyte antigen [HLA] class I cell surface molecule located on the short arm of chromosome 6. It is strongly associated with Acute anterior uveitis [AAU] and Ankylosing spondylitis [AS], the disorders are not only by genetic inherited disease. Several genetic and environmental factors likely play a vital role in determining the risk of developing these disorders. In this study, we try to find out the structure and functional relationship of HLA-B 27 sub types [HLA B[asterisk]27:112, HLA B[asterisk]27:04:01, HLA B[asterisk]27:06, HLA B[asterisk]27:05:02]. The molecular modeling [3D structure] of these subtypes are constructed and ligand binding sites are predicted. The HLA-B 27 gene were amplified from the DNA isolated from the patients with AS and AAU are sequenced. The protein sequences of the HLA-B 27 subtypes obtained from the IMGT/HLA database are aligned with each other and structure of all the subtypes models were constructed by in-silico method. The binding sites of the HLA-B 27 protein and their subtypes was predicted using 3DLigandSite server. The accurate prediction of ligand binding sites on the HLA-B 27 protein surface can be very helpful for rational drug design of AAU and AS

4.
Gulf Medical University: Proceedings. 2015; (4-5 Poster): 96-100
in English | IMEMR | ID: emr-188410

ABSTRACT

This pilot study was initiated with a view to find alpha thalassemia genotypes on de-identified samples from patients diagnosed with anaemia at the Centre for Advanced Biomedical research and Innovation [CABRI] at Gulf Medical University [GMU] in June 2015. Amplified DNA from the samples was probed for mutations using a line probe assay. Results obtained are presented. The study has shown the 3.7 single gene deletion in three cases, and alpha 2 IVS1 [-5nt] mutation seen in one case suggesting these cases have alpha + thalassemia. One sample showed wild type alpha 2 Poly A missing along with the alpha 2 poly a-1 [AATAAA>AATAAG] mutation with a suggestive diagnosis of HbH disease. A SEA double gene deletion was seen in one case suggesting alpha 0-thalassemia. Further studies are being carried out to enhance the data base

5.
Gulf Medical University: Proceedings. 2014; (5-6): 59-66
in English | IMEMR | ID: emr-171682

ABSTRACT

Array comparative genome hybridization [aCGH] has been a powerful tool that allows a high resolution whole genome analysis of copy number variations and single nucleotide polymorphisms [SNPs] that can reveal submicroscopic deletions, duplications loss of homo or heterozygosity [LOH] and uniparental disomy. We present aCGH analysis data of 4 patients referred with autism that was analyzed using a high density oligo/SNP array with over 1.9 million markers for copy number variations [CNV's] and about 750,000 SNPs [Affymetrix]. After careful evaluation, we found no genomic CNVs that were previously described but noticed several regions with loss of heterzygosity [LOH] in 2 of the 4 patients analyzed. The regions of LOH range from 7Mb to over 29Mb in patient A2 and from over 3Mb to over 63Mb in patient A3. Some of the LOH noticed in these patients are seen associated with genes responsible for causing Autism. The genes noticed have been fully characterized and classified as Autism genes. Patient A2 has only one gene involved [DPP10 [2q14.1]] and patient A3 has 5 genes [MBD5 [2q23.1], SCN1A, SCN2A [2q24.3], KCTD13 [16p11.2] and PAFAH1B1 [17p13.3]]. Several regions of LOH detected in these two patients encompass -101 Mb and 201 Mb of the total genome respectively. The results suggest that it is not related to a specific disorder but involvement of at least gene in the LOH region can raise the possibility of a recessive condition. The importance of LOH and the details of the genes will be discussed

SELECTION OF CITATIONS
SEARCH DETAIL